We demonstrated that OMS exerts its antimicrobial effects both directly and via M1-like host protective mechanisms, i.e. upregulation of TNF-α, IL-1β, IL-12B, and iNOS. The gene discussed is TNF; the disease is opsoclonus-myoclonus syndrome.